Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
Every now and again the finite world produces an image so overwhelming in its potential vastness that it offers a glance or impression of the infinite. Like looking into a hall of mirrors. Similarly this afternoon it occurred to me that Andy and Sakura might be two seperate people.
Robin....
Its a tough time for pharma/biotech or many small comps. And SAR need to get into that 1b zone to produce data from humans. That's a common sense reading. Unless someone knows a lot about these kinds of compounds and see value here, at this stage. I'm not a pharma/bio PHD so I can't comment on that.
I'm pretty sure the maths for the shorters is a sub 10p stock. But I always like the possibility of a left-field play - and the maths for anyone trying to play guardian angel with seven figures plus - I imagine that maths is changing on a daily basis.
We shall see. Certainly post-placing there will be a flood of buys - but thats cold comfort, I imagine, if you are already underwater.
I wonder about the bucket shops. Yes that might happen. But it might not. They might have someone they can touch on. They managed to get some interest in 737 - so there are channels between SAR and £ (or in the case it was $?). See what happens. I do feel they are a bit cr*p - as many have said, why on earth didn't they raise when the sp was high - it makes sense to raise when you DON"T need the money - and I don't think enough AIM companies do that. Anyway lets see what happens next.
So...I haven't had time to watch the whole interview but the excerpt on X has Burt saying supportive shareholders and 'debt' - does that mean CLNs? And no ramping or deramping as yet on social - does that mean relevant parties are still talking numbers? Kind of temped to add a few but I suppose it is seriously unwise as the finance will be harsh.
Have a look at SAREUM - in the current climate you don't want to be asking for £. If Synairgen are not earning money - they are not - and sitting on cash the best thing might be to just sit and preserve the cash. And maybe wait a year or so before inching forwards. I don't know if small pharmas are allowed to hibernate but in the current climate there is some sense to it.
I don't think you've been shafted. They just don't have any money and these are very difficult conditions in which to raise cash. They also suffered a delay, if you had to remember and had to shift the trial from UK to Oz - that must have messed up their timelines with regards to producing results and then being able to do the next placing for funds etc.
BTW can someone please share TW's opinion from the bearcast - that would be an interesting read even if you don't agree with him etc
Takeover? I think we need the data from the trials after this one. and this one is not paid for yet. so that is 2 sets of £ to find. I still want to buy but can't see the point until that £ is in the bag. and we can see what sp/dilution will cover those sums. I doubt the company goes bust - isn't it more likely that it just gets more and more and more diluted? Anyway, we shall see.
Trust? I don't feel cheated by Burt. Maybe I missed something. The story seems to be the same as it ever was - he's doing his best to push this company forwards. It must be like pushing a truck up a hill. They are reaching a lot of outlets in the US but that must come at cost (shipping, marketing, staff) - I hope they can pull off a fundraise and keep going.
The FDA have been very supportive. That counts for something. Maybe a lot. And there's always been the odd bit of news that leads to a spike. I thought they might have some news to help the placees off-load. Anyway I'm waiting for 1.4.
There's no possible synchronicity or plan between IB/IQAI and Image Scan Holdings? TB owns a chunk of the latter, there was a Braveheart TR-1 - they are in the image-ing business, but not medical side. i just wondered.
I don't think there's anything wrong with the tech. Trek made a good point re the comms. The company could do more. I guess they don't want to. Or need to. I don't know the MRI space - maybe there is nothing to be gained by raising capital and hiring a powerful sales/marketing team. This is the pace they are working at - for now - they must have their reasons.
It might effectively end up as a transfer of resources from PI's to RFO, the BOD (who will get their share) and eventual JV partner. This does finally break the hold a small group of PI's had if/when they were acting to buy and sell in concert. And the fact that some of them are missing makes me more certain that is exactly what was going on in the past. But this is very challenging for LTHs. Its not a given that LTH's will lose out on any eventual prize - but there must be some doubt about that. And that doubt should be priced in. I'm still not topping up.